US Stock MarketDetailed Quotes

10x Genomics (TXG)

Watchlist

20.520
-0.680-3.21%

Close Jan 16 16:00 ET

20.400
-0.120-0.58%

Post 19:51 ET

2.60BMarket Cap-32.57P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

10x Genomics (TXG) Key Financial Indicators

TXG Free Cash Flow (FCF)

Interested in knowing about 10x Genomics's free cash flow? The latest report shows it as 42.53M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: USD

Quarterly

TXG Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of 10x Genomics shows that the company's current ratio is 4.48, indicating healthy liquidity.

Currency: USD

Quarterly

TXG Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of 10x Genomics, the quick ratio is 3.93, indicating that the company can meet its short-term debt obligations.

Currency: USD

Quarterly

TXG Return on Equity (ROE)

Want to learn more about the financial health of 10x Genomics? The latest ROE figure is -3.53%, indicating that the company has stable profitability.

Currency: USD

Quarterly

TXG Return on Assets (ROA)

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of 10x Genomics, the total asset return on investment (ROA) is -2.74%.

Currency: USD

Quarterly

TXG Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check 10x Genomics's latest financial report to see how their gross margin is doing - currently at 67.32%.

Currency: USD

Quarterly

TXG Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of 10x Genomics, the net profit margin is -18.44%, which is a good sign for its profitability.

Currency: USD

Quarterly